Impact of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging-What Do We Know So Far? (A Narrative Review)

Vascular aging, early vascular aging or supernormal vascular aging are concepts used for estimating the cardiovascular risk at a certain age. From the famous line of Thomas Sydenham that "a man is as old as his arteries" to the present day, clinical studies in the field of molecular biolog...

Full description

Saved in:
Bibliographic Details
Published in:Life (Basel, Switzerland) Switzerland), 2022-05, Vol.12 (6), p.803
Main Authors: Adam, Cristina Andreea, Anghel, Razvan, Marcu, Dragos Traian Marius, Mitu, Ovidiu, Roca, Mihai, Mitu, Florin
Format: Article
Language:English
Subjects:
Aging
arterial stiffness
Arteries
Atherosclerosis
Biomarkers
Blood pressure
Calcification
Cardiovascular diseases
cardiovascular risks
Cell activation
Collagen
Diabetes
Diabetes mellitus
Disease
early vascular aging
Endothelial cells
Endothelium
Extracellular matrix
Fibroblasts
Glucose
Health risks
Heart failure
Homeostasis
Hypertension
Hypoxia
Inhibitors
Low density lipoprotein
Molecular biology
Morbidity
Mortality
Oxidative stress
Review
Risk analysis
Risk factors
SGLT2 inhibitors
Sodium
Stiffness
vascular aging
Vasodilation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c408t-65086fad68000955c90018e5ba03020da811c1660a949c80acba076e4d2cecb73
cites cdi_FETCH-LOGICAL-c408t-65086fad68000955c90018e5ba03020da811c1660a949c80acba076e4d2cecb73
container_end_page
container_issue 6
container_start_page 803
container_title Life (Basel, Switzerland)
container_volume 12
creator Adam, Cristina Andreea
Anghel, Razvan
Marcu, Dragos Traian Marius
Mitu, Ovidiu
Roca, Mihai
Mitu, Florin
description Vascular aging, early vascular aging or supernormal vascular aging are concepts used for estimating the cardiovascular risk at a certain age. From the famous line of Thomas Sydenham that "a man is as old as his arteries" to the present day, clinical studies in the field of molecular biology of the vasculature have demonstrated the active role of vascular endothelium in the onset of cardiovascular diseases. Arterial stiffness is an important cardiovascular risk factor associated with the occurrence of cardiovascular events and a high risk of morbidity and mortality, especially in the presence of diabetes. Sodium-glucose cotransporter 2 inhibitors decrease arterial stiffness and vascular resistance by decreasing endothelial cell activation, stimulating direct vasorelaxation and ameliorating endothelial dysfunction or expression of pro-atherogenic cells and molecules.
doi_str_mv 10.3390/life12060803
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7f9c971079b74662b11160807029ef55</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_7f9c971079b74662b11160807029ef55</doaj_id><sourcerecordid>2679781085</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-65086fad68000955c90018e5ba03020da811c1660a949c80acba076e4d2cecb73</originalsourceid><addsrcrecordid>eNpdkl9v0zAUxSMEYtPYG8_IEi-dRMB2Ev95YaoKKxUVSHSwR-vGcVpXqV3spNM-xr4xLh1Th19s-fx8fO_RzbLXBL8vCok_dLY1hGKGBS6eZacU8yonnMrnR-eT7DzGNU6LVYSJ8mV2UlS8LERRnmb3s80WdI98ixa-scMmn3aD9tGgie8DuLj1oTcBUTRaTOfX9ALN3MrWtvchIu_QeK9a6NCit23rTIwIXIN-QdRDBwGNl9Yt85sV9OiTRzcGfXX-Nn2FriBcotEYfYMQoLc7g36YnTW3F6-yFy100Zw_7GfZz6vP15Mv-fz7dDYZz3NdYtHnrMKCtdAwkRqTVaUlxkSYqgZcYIobEIRowhgGWUotMOikcGbKhmqja16cZbODb-NhrbbBbiDcKQ9W_b3wYakg9FZ3RvFWaskJ5rLmJWO0JoTsI-eYStNWVfL6ePDaDvXGNNq4lF33xPSp4uxKLf1OSUrL9D4ZjB4Mgv89mNirjY3adB0444eoKBMEl0RUJKFv_0PXfgguRZUoLnkCxb6idwdKBx9jMO1jMQSr_eio49FJ-JvjBh7hf4NS_AEMz7xW</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2679781085</pqid></control><display><type>article</type><title>Impact of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging-What Do We Know So Far? (A Narrative Review)</title><source>Access via ProQuest (Open Access)</source><source>PubMed Central</source><creator>Adam, Cristina Andreea ; Anghel, Razvan ; Marcu, Dragos Traian Marius ; Mitu, Ovidiu ; Roca, Mihai ; Mitu, Florin</creator><creatorcontrib>Adam, Cristina Andreea ; Anghel, Razvan ; Marcu, Dragos Traian Marius ; Mitu, Ovidiu ; Roca, Mihai ; Mitu, Florin</creatorcontrib><description>Vascular aging, early vascular aging or supernormal vascular aging are concepts used for estimating the cardiovascular risk at a certain age. From the famous line of Thomas Sydenham that "a man is as old as his arteries" to the present day, clinical studies in the field of molecular biology of the vasculature have demonstrated the active role of vascular endothelium in the onset of cardiovascular diseases. Arterial stiffness is an important cardiovascular risk factor associated with the occurrence of cardiovascular events and a high risk of morbidity and mortality, especially in the presence of diabetes. Sodium-glucose cotransporter 2 inhibitors decrease arterial stiffness and vascular resistance by decreasing endothelial cell activation, stimulating direct vasorelaxation and ameliorating endothelial dysfunction or expression of pro-atherogenic cells and molecules.</description><identifier>ISSN: 2075-1729</identifier><identifier>EISSN: 2075-1729</identifier><identifier>DOI: 10.3390/life12060803</identifier><identifier>PMID: 35743834</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Aging ; arterial stiffness ; Arteries ; Atherosclerosis ; Biomarkers ; Blood pressure ; Calcification ; Cardiovascular diseases ; cardiovascular risks ; Cell activation ; Collagen ; Diabetes ; Diabetes mellitus ; Disease ; early vascular aging ; Endothelial cells ; Endothelium ; Extracellular matrix ; Fibroblasts ; Glucose ; Health risks ; Heart failure ; Homeostasis ; Hypertension ; Hypoxia ; Inhibitors ; Low density lipoprotein ; Molecular biology ; Morbidity ; Mortality ; Oxidative stress ; Review ; Risk analysis ; Risk factors ; SGLT2 inhibitors ; Sodium ; Stiffness ; vascular aging ; Vasodilation</subject><ispartof>Life (Basel, Switzerland), 2022-05, Vol.12 (6), p.803</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-65086fad68000955c90018e5ba03020da811c1660a949c80acba076e4d2cecb73</citedby><cites>FETCH-LOGICAL-c408t-65086fad68000955c90018e5ba03020da811c1660a949c80acba076e4d2cecb73</cites><orcidid>0000-0002-9438-8565 ; 0000-0003-1801-9327 ; 0000-0001-7313-3320</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2679781085/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2679781085?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35743834$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Adam, Cristina Andreea</creatorcontrib><creatorcontrib>Anghel, Razvan</creatorcontrib><creatorcontrib>Marcu, Dragos Traian Marius</creatorcontrib><creatorcontrib>Mitu, Ovidiu</creatorcontrib><creatorcontrib>Roca, Mihai</creatorcontrib><creatorcontrib>Mitu, Florin</creatorcontrib><title>Impact of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging-What Do We Know So Far? (A Narrative Review)</title><title>Life (Basel, Switzerland)</title><addtitle>Life (Basel)</addtitle><description>Vascular aging, early vascular aging or supernormal vascular aging are concepts used for estimating the cardiovascular risk at a certain age. From the famous line of Thomas Sydenham that "a man is as old as his arteries" to the present day, clinical studies in the field of molecular biology of the vasculature have demonstrated the active role of vascular endothelium in the onset of cardiovascular diseases. Arterial stiffness is an important cardiovascular risk factor associated with the occurrence of cardiovascular events and a high risk of morbidity and mortality, especially in the presence of diabetes. Sodium-glucose cotransporter 2 inhibitors decrease arterial stiffness and vascular resistance by decreasing endothelial cell activation, stimulating direct vasorelaxation and ameliorating endothelial dysfunction or expression of pro-atherogenic cells and molecules.</description><subject>Aging</subject><subject>arterial stiffness</subject><subject>Arteries</subject><subject>Atherosclerosis</subject><subject>Biomarkers</subject><subject>Blood pressure</subject><subject>Calcification</subject><subject>Cardiovascular diseases</subject><subject>cardiovascular risks</subject><subject>Cell activation</subject><subject>Collagen</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Disease</subject><subject>early vascular aging</subject><subject>Endothelial cells</subject><subject>Endothelium</subject><subject>Extracellular matrix</subject><subject>Fibroblasts</subject><subject>Glucose</subject><subject>Health risks</subject><subject>Heart failure</subject><subject>Homeostasis</subject><subject>Hypertension</subject><subject>Hypoxia</subject><subject>Inhibitors</subject><subject>Low density lipoprotein</subject><subject>Molecular biology</subject><subject>Morbidity</subject><subject>Mortality</subject><subject>Oxidative stress</subject><subject>Review</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>SGLT2 inhibitors</subject><subject>Sodium</subject><subject>Stiffness</subject><subject>vascular aging</subject><subject>Vasodilation</subject><issn>2075-1729</issn><issn>2075-1729</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkl9v0zAUxSMEYtPYG8_IEi-dRMB2Ev95YaoKKxUVSHSwR-vGcVpXqV3spNM-xr4xLh1Th19s-fx8fO_RzbLXBL8vCok_dLY1hGKGBS6eZacU8yonnMrnR-eT7DzGNU6LVYSJ8mV2UlS8LERRnmb3s80WdI98ixa-scMmn3aD9tGgie8DuLj1oTcBUTRaTOfX9ALN3MrWtvchIu_QeK9a6NCit23rTIwIXIN-QdRDBwGNl9Yt85sV9OiTRzcGfXX-Nn2FriBcotEYfYMQoLc7g36YnTW3F6-yFy100Zw_7GfZz6vP15Mv-fz7dDYZz3NdYtHnrMKCtdAwkRqTVaUlxkSYqgZcYIobEIRowhgGWUotMOikcGbKhmqja16cZbODb-NhrbbBbiDcKQ9W_b3wYakg9FZ3RvFWaskJ5rLmJWO0JoTsI-eYStNWVfL6ePDaDvXGNNq4lF33xPSp4uxKLf1OSUrL9D4ZjB4Mgv89mNirjY3adB0444eoKBMEl0RUJKFv_0PXfgguRZUoLnkCxb6idwdKBx9jMO1jMQSr_eio49FJ-JvjBh7hf4NS_AEMz7xW</recordid><startdate>20220527</startdate><enddate>20220527</enddate><creator>Adam, Cristina Andreea</creator><creator>Anghel, Razvan</creator><creator>Marcu, Dragos Traian Marius</creator><creator>Mitu, Ovidiu</creator><creator>Roca, Mihai</creator><creator>Mitu, Florin</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>P64</scope><scope>PATMY</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9438-8565</orcidid><orcidid>https://orcid.org/0000-0003-1801-9327</orcidid><orcidid>https://orcid.org/0000-0001-7313-3320</orcidid></search><sort><creationdate>20220527</creationdate><title>Impact of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging-What Do We Know So Far? (A Narrative Review)</title><author>Adam, Cristina Andreea ; Anghel, Razvan ; Marcu, Dragos Traian Marius ; Mitu, Ovidiu ; Roca, Mihai ; Mitu, Florin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-65086fad68000955c90018e5ba03020da811c1660a949c80acba076e4d2cecb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Aging</topic><topic>arterial stiffness</topic><topic>Arteries</topic><topic>Atherosclerosis</topic><topic>Biomarkers</topic><topic>Blood pressure</topic><topic>Calcification</topic><topic>Cardiovascular diseases</topic><topic>cardiovascular risks</topic><topic>Cell activation</topic><topic>Collagen</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Disease</topic><topic>early vascular aging</topic><topic>Endothelial cells</topic><topic>Endothelium</topic><topic>Extracellular matrix</topic><topic>Fibroblasts</topic><topic>Glucose</topic><topic>Health risks</topic><topic>Heart failure</topic><topic>Homeostasis</topic><topic>Hypertension</topic><topic>Hypoxia</topic><topic>Inhibitors</topic><topic>Low density lipoprotein</topic><topic>Molecular biology</topic><topic>Morbidity</topic><topic>Mortality</topic><topic>Oxidative stress</topic><topic>Review</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>SGLT2 inhibitors</topic><topic>Sodium</topic><topic>Stiffness</topic><topic>vascular aging</topic><topic>Vasodilation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adam, Cristina Andreea</creatorcontrib><creatorcontrib>Anghel, Razvan</creatorcontrib><creatorcontrib>Marcu, Dragos Traian Marius</creatorcontrib><creatorcontrib>Mitu, Ovidiu</creatorcontrib><creatorcontrib>Roca, Mihai</creatorcontrib><creatorcontrib>Mitu, Florin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Life (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adam, Cristina Andreea</au><au>Anghel, Razvan</au><au>Marcu, Dragos Traian Marius</au><au>Mitu, Ovidiu</au><au>Roca, Mihai</au><au>Mitu, Florin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging-What Do We Know So Far? (A Narrative Review)</atitle><jtitle>Life (Basel, Switzerland)</jtitle><addtitle>Life (Basel)</addtitle><date>2022-05-27</date><risdate>2022</risdate><volume>12</volume><issue>6</issue><spage>803</spage><pages>803-</pages><issn>2075-1729</issn><eissn>2075-1729</eissn><abstract>Vascular aging, early vascular aging or supernormal vascular aging are concepts used for estimating the cardiovascular risk at a certain age. From the famous line of Thomas Sydenham that "a man is as old as his arteries" to the present day, clinical studies in the field of molecular biology of the vasculature have demonstrated the active role of vascular endothelium in the onset of cardiovascular diseases. Arterial stiffness is an important cardiovascular risk factor associated with the occurrence of cardiovascular events and a high risk of morbidity and mortality, especially in the presence of diabetes. Sodium-glucose cotransporter 2 inhibitors decrease arterial stiffness and vascular resistance by decreasing endothelial cell activation, stimulating direct vasorelaxation and ameliorating endothelial dysfunction or expression of pro-atherogenic cells and molecules.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35743834</pmid><doi>10.3390/life12060803</doi><orcidid>https://orcid.org/0000-0002-9438-8565</orcidid><orcidid>https://orcid.org/0000-0003-1801-9327</orcidid><orcidid>https://orcid.org/0000-0001-7313-3320</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2075-1729
ispartof Life (Basel, Switzerland), 2022-05, Vol.12 (6), p.803
issn 2075-1729
2075-1729
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7f9c971079b74662b11160807029ef55
source Access via ProQuest (Open Access); PubMed Central
subjects Aging
arterial stiffness
Arteries
Atherosclerosis
Biomarkers
Blood pressure
Calcification
Cardiovascular diseases
cardiovascular risks
Cell activation
Collagen
Diabetes
Diabetes mellitus
Disease
early vascular aging
Endothelial cells
Endothelium
Extracellular matrix
Fibroblasts
Glucose
Health risks
Heart failure
Homeostasis
Hypertension
Hypoxia
Inhibitors
Low density lipoprotein
Molecular biology
Morbidity
Mortality
Oxidative stress
Review
Risk analysis
Risk factors
SGLT2 inhibitors
Sodium
Stiffness
vascular aging
Vasodilation
title Impact of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging-What Do We Know So Far? (A Narrative Review)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T16%3A48%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Sodium-Glucose%20Cotransporter%202%20(SGLT2)%20Inhibitors%20on%20Arterial%20Stiffness%20and%20Vascular%20Aging-What%20Do%20We%20Know%20So%20Far?%20(A%20Narrative%20Review)&rft.jtitle=Life%20(Basel,%20Switzerland)&rft.au=Adam,%20Cristina%20Andreea&rft.date=2022-05-27&rft.volume=12&rft.issue=6&rft.spage=803&rft.pages=803-&rft.issn=2075-1729&rft.eissn=2075-1729&rft_id=info:doi/10.3390/life12060803&rft_dat=%3Cproquest_doaj_%3E2679781085%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c408t-65086fad68000955c90018e5ba03020da811c1660a949c80acba076e4d2cecb73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2679781085&rft_id=info:pmid/35743834&rfr_iscdi=true